NO994932L - Blandinger og fremgangsmåter for behandling og diagnose av brystkreft - Google Patents
Blandinger og fremgangsmåter for behandling og diagnose av brystkreftInfo
- Publication number
- NO994932L NO994932L NO994932A NO994932A NO994932L NO 994932 L NO994932 L NO 994932L NO 994932 A NO994932 A NO 994932A NO 994932 A NO994932 A NO 994932A NO 994932 L NO994932 L NO 994932L
- Authority
- NO
- Norway
- Prior art keywords
- breast cancer
- methods
- mixtures
- treating
- diagnosing breast
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 5
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83876297A | 1997-04-09 | 1997-04-09 | |
| US08/991,789 US6225054B1 (en) | 1996-01-11 | 1997-12-11 | Compositions and methods for the treatment and diagnosis of breast cancer |
| PCT/US1998/006939 WO1998045328A2 (en) | 1997-04-09 | 1998-04-09 | Compositions and methods for the treatment and diagnosis of breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994932D0 NO994932D0 (no) | 1999-10-08 |
| NO994932L true NO994932L (no) | 1999-12-07 |
Family
ID=27126060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994932A NO994932L (no) | 1997-04-09 | 1999-10-08 | Blandinger og fremgangsmåter for behandling og diagnose av brystkreft |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP1127893A2 (ko) |
| JP (1) | JP4270523B2 (ko) |
| KR (1) | KR20010006220A (ko) |
| AU (1) | AU6956098A (ko) |
| BR (1) | BR9808509A (ko) |
| CA (1) | CA2286348A1 (ko) |
| IL (1) | IL132287A0 (ko) |
| NO (1) | NO994932L (ko) |
| PL (1) | PL336349A1 (ko) |
| TR (1) | TR199903154T2 (ko) |
| WO (1) | WO1998045328A2 (ko) |
| ZA (1) | ZA982968B (ko) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6656480B2 (en) | 1996-01-11 | 2003-12-02 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| US7241876B2 (en) | 1996-01-11 | 2007-07-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6828431B1 (en) | 1999-04-09 | 2004-12-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6344550B1 (en) | 1996-01-11 | 2002-02-05 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| US6586570B1 (en) | 1996-01-11 | 2003-07-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| US20030125536A1 (en) * | 1996-01-11 | 2003-07-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US20020068285A1 (en) * | 1996-01-11 | 2002-06-06 | Frudakis Tony N. | Compositions and methods for the therapy and diagnosis of breast cancer |
| US6861506B1 (en) | 1996-01-11 | 2005-03-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| US6225054B1 (en) | 1996-01-11 | 2001-05-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| US7598226B2 (en) | 1998-12-28 | 2009-10-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| HUP0200825A2 (en) * | 1999-04-09 | 2002-07-29 | Corixa Corp | Compositions and methods for the treatment and diagnosis of breast cancer |
| AU2004218695B2 (en) * | 1999-04-09 | 2008-05-08 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
| GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| EP1248800A2 (en) | 1999-11-30 | 2002-10-16 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
| EP1250426A2 (en) * | 1999-12-01 | 2002-10-23 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding same |
| ES2281416T3 (es) * | 2000-04-03 | 2007-10-01 | Corixa Corporation | Metodos, composiciones y sistemas para la deteccion y monitorizacion del cancer de mama. |
| ES2392943T3 (es) | 2000-10-18 | 2012-12-17 | Glaxosmithkline Biologicals S.A. | Vacunas antitumorales |
| WO2002059377A2 (en) * | 2001-01-24 | 2002-08-01 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| WO1991002062A2 (en) * | 1989-08-04 | 1991-02-21 | Triton Biosciences, Inc. | C-erbb-2 external domain: gp75 |
| US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
| WO1995019369A1 (en) * | 1994-01-14 | 1995-07-20 | Vanderbilt University | Method for detection and treatment of breast cancer |
| AU2690995A (en) * | 1994-05-23 | 1995-12-18 | Calypte Inc. | Non-hiv antibodies as disease markers |
| US5668267A (en) * | 1995-05-31 | 1997-09-16 | Washington University | Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
| CA2228999A1 (en) * | 1995-08-09 | 1997-02-20 | Institut National De La Sante Et De La Recherche Medicale | Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| AU1575697A (en) * | 1996-01-10 | 1997-08-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of cancer |
| KR19990077146A (ko) * | 1996-01-11 | 1999-10-25 | 길리스 스티브 | 유방암의 치료 및 진단용 조성물 및 방법 |
-
1998
- 1998-04-07 ZA ZA982968A patent/ZA982968B/xx unknown
- 1998-04-09 EP EP01100737A patent/EP1127893A2/en not_active Withdrawn
- 1998-04-09 EP EP98915351A patent/EP0975666A2/en not_active Withdrawn
- 1998-04-09 CA CA002286348A patent/CA2286348A1/en not_active Abandoned
- 1998-04-09 TR TR1999/03154T patent/TR199903154T2/xx unknown
- 1998-04-09 BR BR9808509-3A patent/BR9808509A/pt not_active IP Right Cessation
- 1998-04-09 WO PCT/US1998/006939 patent/WO1998045328A2/en not_active Application Discontinuation
- 1998-04-09 KR KR1019997009300A patent/KR20010006220A/ko not_active Application Discontinuation
- 1998-04-09 EP EP08075288A patent/EP1964850A3/en not_active Withdrawn
- 1998-04-09 AU AU69560/98A patent/AU6956098A/en not_active Abandoned
- 1998-04-09 PL PL98336349A patent/PL336349A1/xx unknown
- 1998-04-09 JP JP54305998A patent/JP4270523B2/ja not_active Expired - Lifetime
- 1998-04-09 IL IL13228798A patent/IL132287A0/xx unknown
-
1999
- 1999-10-08 NO NO994932A patent/NO994932L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010006220A (ko) | 2001-01-26 |
| JP2001521384A (ja) | 2001-11-06 |
| BR9808509A (pt) | 2001-09-18 |
| EP1964850A2 (en) | 2008-09-03 |
| WO1998045328A3 (en) | 1999-04-22 |
| TR199903154T2 (xx) | 2000-08-21 |
| PL336349A1 (en) | 2000-06-19 |
| WO1998045328A2 (en) | 1998-10-15 |
| EP0975666A2 (en) | 2000-02-02 |
| EP1964850A3 (en) | 2012-06-20 |
| IL132287A0 (en) | 2001-03-19 |
| NO994932D0 (no) | 1999-10-08 |
| EP1127893A2 (en) | 2001-08-29 |
| AU6956098A (en) | 1998-10-30 |
| ZA982968B (en) | 1998-10-27 |
| JP4270523B2 (ja) | 2009-06-03 |
| CA2286348A1 (en) | 1998-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994932L (no) | Blandinger og fremgangsmåter for behandling og diagnose av brystkreft | |
| EP1876241A3 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| NO20004631L (no) | Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft | |
| HUP0203035A2 (hu) | Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások | |
| WO2003087831A3 (en) | Proteins involved in breast cancer | |
| DE59705683D1 (de) | IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG | |
| ATE399793T1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| NO20016427D0 (no) | Blandinger og fremgangsmåter for behandling av diagnose av lungekreft | |
| HUP0203968A2 (hu) | Készítmények és eljárások prosztatarák terápiájára és diagnózisára | |
| NO20014769D0 (no) | Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav | |
| ATE419516T1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| WO2000052165A3 (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| WO2001018046A3 (en) | Ovarian tumor sequences and methods of use therefor | |
| IL151448A0 (en) | Proteins | |
| ATE514780T1 (de) | Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon | |
| MXPA01010186A (es) | Composiciones y metodos para el tratamiento y diagnostico de cancer de mama. | |
| BR0111024A (pt) | Composições e métodos para a terapia e diagnóstico de câncer de mama | |
| WO1999037775A3 (en) | Compositions and methods for detecting and treating breast cancer | |
| DE60139150D1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| WO1999054466A3 (en) | Colon cancer-associated antigens and their diagnostic and therapeutic uses | |
| ATE291738T1 (de) | Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen | |
| WO2000073338A8 (en) | Compositions and methods for the therapy, diagnosis and monitoring of breast cancer | |
| WO1999037778A3 (en) | Compositions and methods for detecting and treating prostate cancer | |
| ATE291620T1 (de) | Mammakarzinom-assoziiertes gen | |
| AR012389A1 (es) | Composiciones y metodos para el tratamiento y diagnostico del cancer de seno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |